Showing results (21-30 of 764) with videos related to
Sort By:
Pageof 77
Journal of the National Cancer Institute. Monographs|December 29, 2012
Role of active surveillance in the management of localized prostate cancerAllison S Glass, Matthew R Cooperberg, Maxwell V Meng, et al.The Journal of Urology|July 24, 2007
Contemporary trends in low risk prostate cancer: risk assessment and treatmentMatthew R Cooperberg, Jeannette M Broering, Philip W Kantoff, et al.BJU International|September 20, 2014
Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancerMatthew R Cooperberg, Shiro Hinotsu, Mikio Namiki, et al.World Journal of Urology|February 25, 2011
The example of CaPSURE: lessons learned from a national disease registrySima P Porten, Matthew R Cooperberg, Badrinath R Konety, et al.The Journal of Urology|November 12, 2003
Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE)Matthew R Cooperberg, Deborah P Lubeck, Shilpa S Mehta, et al.Journal of the National Cancer Institute|July 3, 2003
National practice patterns and time trends in androgen ablation for localized prostate cancerMatthew R Cooperberg, Gary D Grossfeld, Deborah P Lubeck, et al.European Urology|April 22, 2014
Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristicsMohamed Jalloh, Frank Myers, Janet E Cowan, et al.Cancer|May 21, 2008
Renal cell cancer stage migration: analysis of the National Cancer Data BaseChristopher J Kane, Katherine Mallin, Jamie Ritchey, et al.Current Opinion in Urology|August 23, 2019
Active surveillance for intermediate-risk prostate cancer: yes, but for whom?Maya R Overland, Samuel L Washington, Peter R Carroll, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Urologist density and county-level urologic cancer mortalityAnobel Y Odisho, Matthew R Cooperberg, Vincent Fradet, et al.Pageof 77